James V. (Jim) Mazzo is Global President for Carl Zeiss Meditec’s Strategic Business Unit Ophthalmic Devices, which includes Ophthalmic Diagnostics, Surgical Ophthalmology and Refractive Lasers. Carl Zeiss Meditec has the broadest line of diagnostic and surgical products in the industry and has been an innovative leader in medical technology for over 100 years. Mazzo is one of the ophthalmic industry’s best known and most respected business leaders with over 38 years of proven experience. His global reputation for building and running world-class organizations is based on 22 years leading Allergan’s North American and European eye care organizations; 7 years as Chairman, President and CEO of Advanced Medical Optics (AMO); 4 years as EVP of Abbott’s global ophthalmology business; 3 years as Executive Chair and CEO of AcuFocus. Additionally, he is Chairman of Neurotech, a retinal implant company; on the Board of Directors for Avellino Labs, a biotechnology and genetic science company; and is founder and on the executive committee of OCTANe. He is a member of the International Intraocular Implant Club (lllC), is Leerink’s Special Advisor Medical Devices and is Executive Committee Board Member with the Medical Device Manufacturers Association (MDMA). Mazzo is on the ASCRS Governing Board, the AAO Foundation Advisory Board, the ICO Foundation Advisory Board, the AGS Foundation Advisory Board, serves on NASA’s Mission to Mars Committee and is an Officer in the Order of St. John.